Neuland Laboratories Ltd
NSE:NEULANDLAB

Watchlist Manager
Neuland Laboratories Ltd Logo
Neuland Laboratories Ltd
NSE:NEULANDLAB
Watchlist
Price: 12 050 INR -3.4%
Market Cap: 154.6B INR

Neuland Laboratories Ltd
Investor Relations

Neuland Laboratories Ltd., with its roots firmly planted in the bustling pharmaceutical sector of India, presents a captivating narrative of innovation and strategic growth. Founded in 1984 by Dr. D.R. Rao, the venture initially embarked on its journey by manufacturing Active Pharmaceutical Ingredients (APIs), essential components that power numerous medical treatments. Situated in Hyderabad, the company swiftly carved out a niche by focusing on complex and high-value APIs, earning a reputation for quality and reliability. This strategy enabled Neuland to establish long-standing relationships with prominent generic pharmaceutical companies across the globe.

As the world of pharmaceuticals evolved, so did Neuland's approach to business. The company shifted gears to not just produce APIs but also ventured into Contract Research and Manufacturing Services (CRAMS), capitalizing on the growing demand for customized pharmaceutical development and production services. This not only diversified their revenue streams but also aligned them with the needs of various pharmaceutical innovators striving for precision and customization in their drug formulations. With a commitment to regulatory compliance and a robust infrastructural foundation, Neuland Laboratories continues to bolster its position in the market, marrying its time-honored expertise in chemistry with cutting-edge technological advancements to drive profitability and sustain its international footprint.

Show more
Loading
NEULANDLAB
BSE Sensex 30

Earnings Calls

2025 Q2
Apr 3, 2025
Show Transcript
Previous
Next
Lindsay Corporation Reports Strong Growth in Q2 Fiscal 2025
2025 Q2
Apr 3, 2025

Lindsay Corporation achieved a remarkable 23% revenue increase in Q2 fiscal 2025, totaling $187.1 million, with net earnings soaring 47% to $26.6 million. The irrigation segment saw an 11% revenue rise, despite a 7% decline in North America, while international irrigation revenues surged by 42%, driven by significant projects in the MENA region. The infrastructure segment revenues more than doubled to $38.9 million, fueled by a completed $20 million project. Looking ahead, the company anticipates stable irrigation equipment demand in North America and project growth in developing international markets, while managing a potential mid-single-digit cost impact from tariffs.

Show Full Analysis

Management

Dr. Davuluri Rama Mohan Rao
Executive Chairman & Chief Promoter and Member of Scientific Advisory Board
No Bio Available
Mr. Davuluri Sucheth Rao
Vice Chairman & CEO
No Bio Available
Mr. Davuluri Saharsh Rao
Vice Chairman & MD
No Bio Available
Mr. Abhijit Majumdar
Chief Financial Officer
No Bio Available
Dr. Sharadsrikar Venkatesan Kotturi
Chief Scientific Officer & Member of Scientific Advisory Board
No Bio Available
Ms. Sarada Bhamidipati
Company Secretary & Compliance Officer
No Bio Available
Mr. Sudheer Yarabolu
Senior VP of Global Head Sales & BD
No Bio Available
Mr. Hemchandra Peruvelli
Chief Human Resources Officer
No Bio Available
Mr. Y. Sudheer
Senior Vice President of Global API Sales
No Bio Available
Mr. N. Sundar
Chief Procurement Officer
No Bio Available

Contacts

Address
TELANGANA
Hyderabad
Sanali Info Park, A Block, Ground Floor, 8-2-120/113, Road No. 2, Banjara Hills
Contacts
+914030211600
www.neulandlabs.com